首页> 外文期刊>Journal of Biomolecular Structure and Dynamics >Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH)
【24h】

Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH)

机译:汇总高吞吐量虚拟筛选,对接和分子动力学模拟的多种电子药物模型,以发现疟原虫乳酸脱氢酶(PFLDH)的潜在抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

ABSTRACT: Development of new antimalarial drugs continues to be of huge importance because of the resistance of malarial parasite towards currently used drugs. Due to the reliance of parasite on glycolysis for energy generation, glycolytic enzymes have played important role as potential targets for the development of new drugs. Plasmodium falciparum lactate dehydrogenase (PfLDH) is a key enzyme for energy generation of malarial parasites and is considered to be a potential antimalarial target. Presently, there are nearly 15 crystal structures bound with inhibitors and substrate that are available in the protein data bank (PDB). In the present work, we attempted to consider multiple crystal structures with bound inhibitors showing affinity in the range of 1.4 × 10 2 –1.3 × 10 6 nM efficacy and optimized the pharmacophore based on the energy involved in binding termed as e-pharmacophore mapping. A high throughput virtual screening (HTVS) combined with molecular docking, ADME predictions and molecular dynamics simulation led to the identification of 20 potential compounds which could be further developed as novel inhibitors for PfLDH. ? 2018, ? 2018 Informa UK Limited, trading as Taylor & Francis Group.
机译:摘要:新的抗疟药的开发仍然具有重要的重要性,因为疟疾寄生虫对目前使用的药物的抵抗力。由于寄生虫对能量产生的糖醇酰胺,糖酵解酶发挥了重要作用作为新药开发的潜在目标。疟原疟原虫乳酸脱氢酶(PFLDH)是疟疾寄生虫能量产生的关键酶,被认为是潜在的抗疟靶。目前,存在近15个晶体结构与蛋白质数据库(PDB)中可用的抑制剂和底物结合。在目前的工作中,我们试图考虑具有结合抑制剂的多个晶体结构,所述结合抑制剂显示在1.4×10 2 -1.3×10 6nm功效范围内的亲和力,并基于所涉及作为电子药物模型的结合所涉及的能量优化药效线。高吞吐量虚拟筛选(HTVS)与分子对接相结合,ADME预测和分子动力学模拟导致20个潜在化合物,其可以进一步开发为PFLDH的新型抑制剂。还2018年,? 2018年Informa UK Limited,贸易为泰勒&弗朗西斯集团。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号